Lack of TIGIT expression in NK cells in vivo retarded tumor growth, and blockade of TIGIT action via mAb reversed antitumor NK cell exhaustion in multiple tumor models, resulting in increased overall host survival [113]. The gene discussed is TIGIT; the disease is neoplasm.